Filed before 2025Filed 9 September 2022
Arsenal Biosciences, Inc. raised $33M
Arsenal Biosciences, Inc., a biotech company based in South San Francisco, CA, raised $33M in a new equity round, according to a filing dated 9 September 2022.
Raises filed before 2025 are not checked for a public announcement.
- Filed
- 9 September 2022
- Round
- Equity round
- Amount sold
- $33M
- Offering size
- $33M
- Investors so far
- 9
- Based in
- South San Francisco, CA
Investors on the board
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
1 director of this company is named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 81% of the 1,764 tracked raises with an amount filed in 2022, and than 79% of the 142 in biotech.
Arsenal Biosciences, Inc. in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 4 Sep 2024 | New filing | $325M | Another raise |
| 9 Sep 2022 | New filing | $221M | Another raise |
| 9 Sep 2022 | New filing | $33M | This raise |
More with Westlake BioPartners on the board
Other unannounced rounds
- DVx Atomic Co.$18.5M
- Aperio Systems, Inc.$1.6M
- Twin Health, Inc.$59M
- Scoring Factory AI Inc.$500K
- Royal & Pelham, Inc.$5.4M
- SPECTRA Holdings US, Ltd.$2.5M
Seen it announced?
Send the link and the check will look at it.